About Michael Silber

This author has not yet filled in any details.
So far Michael Silber has created 2747 blog entries.

Oklahoma

The State Board of Pharmacy (OSBP) is requesting that pharmacies email the following information within 24 hours of pharmacy closure during normal business hours, during the time when patients would expect the pharmacy to be open.  

  • License number of the pharmacy 
  • Name of the pharmacy 
  • Address of the pharmacy 
  • Name of the Pharmacist in charge (PIC)
  • Dates that the pharmacy will be closed 
  • Hours the pharmacy will be closed 
  • Detailed explanation for closing 

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2022-07-22T11:38:45-04:00July 22, 2022|Oklahoma|

Oregon

The Oregon State Newsletter – June 2022 has been posted to the NABP/Oregon website and includes the following information. 

  • No. 678 Safe Pharmacy Practice Conditions 
  • No. 679 Expedited Partner Therapy Updates 
  • No. 680 Rulemaking
  • Rule Feedback 
  • Permanent Rules Adopted in April 2022
  • Permanent Rules Adopted in June 2022
  • No. 681 Compliance: Legal Advice vs Legal Information 
  • No. 682 Licensing: Technician Renewals Due June 30, 2022 
  • No. 683 REALD and Pharmacies 

Also in Oregon, the Board of Pharmacy adopted the following temporary rules effective July 1, 2022, through December 27, 2022. 

  • OAR 855-019-0210 related to Duties of Pharmacist Receiving a Prescription  
  • OAR 855-139-0699 related to a Retail Drug Outlet RDSP (Remote Dispensing Site Pharmacy) 

Also in Oregon, the Board of Pharmacy adopted the following permanent rules at the June 2022 Board Meeting. 

Finally in Oregon, effective July 1, 2022, through December 27, 2022, the Oregon Health Authority adopted a temporary rule amending OAR 410-121-0030 and 410-121-0040 in accordance with the Drug Use Review (DUR) Pharmacy & Therapeutics (P&T) Committee's recommendations made during the June 2, 2022 meeting.   

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

2022-07-22T11:37:46-04:00July 22, 2022|Oregon|

South Carolina

The South Carolina Pharmacy Association (SCPhA) is seeking a new Chief Executive Officer. The selection process will begin in July 2022 and continue until the best candidate is identified. Questions may be directed to the Selection Committee c/o Jennifer Baker, SCPhA Immediate‐Past President & Search Committee Chair at scpharmacyjlb@gmail.com

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2022-07-22T11:36:06-04:00July 22, 2022|South Carolina|

Texas

The Board of Pharmacy August 2nd meeting agenda includes proposed rules for final adoption on patient counseling, non-sterile compounding, and centralized prescription dispensing. If you are unable to attend the Board meeting, you can watch it on live stream 

Also in Texas, NACDS sponsored the Texas Pharmacy Association’s annual meeting keynote session with State Senator Charles Perry (R-Lubbock), the Vice-Chair of the powerful Senate Health and Human Services Committee. Last session, Sen. Perry, a vocal advocate for pharmacy benefit manager (PBM) reform, helped pass two important bills through the Senate that became law in 2021.  

Also in Texas, NACDS and our in-state partner, the Texas Federation of Drug Stores, have arranged for Rep. Four Price (R) to tour a United Supermarket Pharmacy in Amarillo. (Left to Right: United pharmacist Tim Purser, pharmacy technician Danielle Coleman, pharmacist Viet Le Nguyen, NACDS’ TX lobbyist Nicole Kralj, State Rep. Four Price (R-Amarillo) and NACDS Mary Staples) 

Finally in Texas, Gov. Greg Abbott (R) again extended the waiver for the requirement for pharmacists to have in-person contact for patient counseling to allow patient counseling to be performed by telephonic consultation until September 30, 2022, or until the March 13, 2020, disaster declaration is lifted or expires, whichever is earlier.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2022-07-22T11:35:32-04:00July 22, 2022|Texas|

California

On June 27, Gov. Gavin Newsom (D) signed SB (Senate Bill) 154 (Chapter 43) which includes language allocating $114.4 million to forgive the retroactive reduction of claims reimbursement for independent pharmacies in 2022-23. Another $28.4 million will be allocated in 2023-24. This was due to an error in the implementation of the actual acquisition cost reimbursement methodology for dates of service from April 1, 2017, to February 22, 2019, inclusive. On June 30, Gov. Newsom signed AB (Assembly Bill) 178 (Chapter 45) that directs the Department of Health Care Services to forego the recoupment of overpayments from independent pharmacies and defined "independent pharmacy" as a pharmacy owned by a person or entity who owns not more than 74 pharmacies in California. Also, on June 30, the Governor signed SB 184 (Chapter 47), the health trailer bill, that expands telehealth and exempts continuous glucose monitors and medication therapy management services from a 10 percent provider cut based on 2011 legislation.  

Also in California, the Department of Consumer Affairs issued this waiver extension on July 11: DCA Waiver DCA-22-217 Order Waiving Restrictions on Pharmacists Independently Initiating and Furnishing Paxlovid to Individual Patients. The full waiver and a list of current waivers is available on the DCA website. 

Also in California, the Board of Pharmacy recently communicated the following: 

Also in California, the Department of Health Care Services posted the following alerts on theMedi-Cal Rx Web Portal. Please note this week's announcement about the postponement of implementation of NCPDP (National Council for Prescription Drug Programs) reject code 80 and the reminder about the July 31 deadline for all participating Medi-Cal Rx pharmacy providers and billers to submit a Medi-Cal Rx Telecommunications Provider and Biller Application/Agreement Form to continue submitting electronic claims without interruption. 

Finally in California, the Department of Health Care Services posted the "August 2022 Medi-Cal Provider Training Webinars". 

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

2022-07-15T08:07:19-04:00July 15, 2022|California|

Delaware

Both Houses of the legislature passed SB 399 that authorizes a pharmacist to order, test, screen, and treat certain health conditions pursuant to a statewide written protocol for CLIA waived tests approved by the Division of Public Health. This legislation is pending Governor Carney’s (D) signature.

For more information, please contact NACDS’ Mike Sargent at 207-272-6435.

2022-07-15T08:06:13-04:00July 15, 2022|Delaware|

Florida

Governor Ron DeSantis (R) issued an Executive Order to address the cost of prescription drugs in the state. The order directs all executive agencies to include provisions in all future contracts and solicitations with PBMs (Pharmacy Benefits Managers) (Pharmacy Benefit Manager), services that include the following:  

  • Prohibit spread pricing for all PBMs 
  • Prohibit reimbursement claw backs for all PBMs 
  • Directs agencies to include reporting requirements and data transparency, including a review of all rebates, payments, and relationships between pharmacies, insurers, and manufacturers 
  • Directs all impacted agencies to amend all contracts with these same provisions. 

Also in Florida, the Agency for Health Care Administration (Agency) has been implementing Referring, Ordering, Prescribing, and Attending (ROPA) requirements as directed by the 21st Century Cures Act (Cures Act) and by the Centers for Medicare and Medicaid Services (CMS). Previous provider alerts on National Provider Identifier (NPI) requirements for ROPA providers can be found on the Agency's website in the Provider Message Archive. Providers must be enrolled with Florida Medicaid in accordance with Title 42, Code of Federal Regulations, Section 455.410(b). 

In accordance with CMS requirements, all Fee-For-Service claims submitted October 1, 2022, or after from a non-exempt provider type that do not have a ROPA provider listed on the claim will be denied. The exempted provider types that will not require a ROPA on the claim are listed below, all other provider type claims must have a ROPA provider identified by NPI on the claim for reimbursement by Florida Medicaid. 

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2022-07-15T08:05:37-04:00July 15, 2022|Florida|
Go to Top